These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33495337)

  • 61. High-mobility group box 1-mediated heat shock protein beta 1 expression attenuates mitochondrial dysfunction and apoptosis.
    Narumi T; Shishido T; Otaki Y; Kadowaki S; Honda Y; Funayama A; Honda S; Hasegawa H; Kinoshita D; Yokoyama M; Nishiyama S; Takahashi H; Arimoto T; Miyamoto T; Watanabe T; Tanaka A; Woo CH; Abe J; Takeishi Y; Kubota I
    J Mol Cell Cardiol; 2015 May; 82():1-12. PubMed ID: 25736854
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neonatal murine engineered cardiac tissue toxicology model: Impact of dexrazoxane on doxorubicin induced injury.
    Zhen J; Yu H; Ji H; Cai L; Leng J; Keller BB
    Life Sci; 2019 Dec; 239():117070. PubMed ID: 31751580
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Protease-activated receptor 1 activation enhances doxorubicin-induced cardiotoxicity.
    Antoniak S; Tatsumi K; Schmedes CM; Grover SP; Pawlinski R; Mackman N
    J Mol Cell Cardiol; 2018 Sep; 122():80-87. PubMed ID: 30098988
    [TBL] [Abstract][Full Text] [Related]  

  • 64. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products.
    Boyd JH; Kan B; Roberts H; Wang Y; Walley KR
    Circ Res; 2008 May; 102(10):1239-46. PubMed ID: 18403730
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rac1-mediated cardiac damage causes diastolic dysfunction in a mouse model of subacute doxorubicin-induced cardiotoxicity.
    Ohlig J; Henninger C; Zander S; Merx M; Kelm M; Fritz G
    Arch Toxicol; 2018 Jan; 92(1):441-453. PubMed ID: 28710503
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Doxorubicin enhances oxysterol levels resulting in a LXR-mediated upregulation of cardiac cholesterol transporters.
    Monzel JV; Budde T; Meyer Zu Schwabedissen HE; Schwebe M; Bien-Möller S; Lütjohann D; Kroemer HK; Jedlitschky G; Grube M
    Biochem Pharmacol; 2017 Nov; 144():108-119. PubMed ID: 28807695
    [TBL] [Abstract][Full Text] [Related]  

  • 67. LncRNA FOXC2-AS1 protects cardiomyocytes from doxorubicin-induced cardiotoxicity through activation of WNT1-inducible signaling pathway protein-1.
    Zhang S; Yuan Y; Zhang Z; Guo J; Li J; Zhao K; Qin Y; Qiu C
    Biosci Biotechnol Biochem; 2019 Apr; 83(4):653-658. PubMed ID: 30558506
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity.
    Cao Y; Shen T; Huang X; Lin Y; Chen B; Pang J; Li G; Wang Q; Zohrabian S; Duan C; Ruan Y; Man Y; Wang S; Li J
    Oncotarget; 2017 Jan; 8(3):4837-4848. PubMed ID: 27902477
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Spinochrome D Attenuates Doxorubicin-Induced Cardiomyocyte Death via Improving Glutathione Metabolism and Attenuating Oxidative Stress.
    Yoon CS; Kim HK; Mishchenko NP; Vasileva EA; Fedoreyev SA; Stonik VA; Han J
    Mar Drugs; 2018 Dec; 17(1):. PubMed ID: 30577438
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nucleolin protects against doxorubicin-induced cardiotoxicity via upregulating microRNA-21.
    Sun H; Tong Z; Fang Y; Jiang B; Liang P; Tang Y; Li Y; Wu Y; Xiao X
    J Cell Physiol; 2018 Dec; 233(12):9516-9525. PubMed ID: 29968904
    [TBL] [Abstract][Full Text] [Related]  

  • 71. MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2.
    Tong Z; Jiang B; Wu Y; Liu Y; Li Y; Gao M; Jiang Y; Lv Q; Xiao X
    Int J Mol Sci; 2015 Jun; 16(7):14511-25. PubMed ID: 26132560
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rutin attenuates doxorubicin-induced cardiotoxicity via regulating autophagy and apoptosis.
    Ma Y; Yang L; Ma J; Lu L; Wang X; Ren J; Yang J
    Biochim Biophys Acta Mol Basis Dis; 2017 Aug; 1863(8):1904-1911. PubMed ID: 28069395
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity.
    Lazzarini E; Balbi C; Altieri P; Pfeffer U; Gambini E; Canepa M; Varesio L; Bosco MC; Coviello D; Pompilio G; Brunelli C; Cancedda R; Ameri P; Bollini S
    Sci Rep; 2016 Jul; 6():29994. PubMed ID: 27444332
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of a Hydrophobic Pocket in Polyamine Interactions with the Polyspecific Organic Cation Transporter OCT3.
    Li DC; Nichols CG; Sala-Rabanal M
    J Biol Chem; 2015 Nov; 290(46):27633-43. PubMed ID: 26405039
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cardiac Fgf-16 Expression Supports Cardiomyocyte Survival and Increases Resistance to Doxorubicin Cytotoxicity.
    Wang J; Xiang B; Dolinsky VW; Kardami E; Cattini PA
    DNA Cell Biol; 2018 Nov; 37(11):866-877. PubMed ID: 30230915
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Protection against Doxorubicin-Related Cardiotoxicity by Jaceosidin Involves the Sirt1 Signaling Pathway.
    Liu Y; Zhou L; Du B; Liu Y; Xing J; Guo S; Li L; Chen H
    Oxid Med Cell Longev; 2021; 2021():9984330. PubMed ID: 34422218
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy.
    Xia P; Liu Y; Chen J; Coates S; Liu DX; Cheng Z
    J Biol Chem; 2018 Dec; 293(51):19672-19685. PubMed ID: 30361442
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Exposing cardiomyocytes to subclinical concentrations of doxorubicin rapidly reduces their creatine transport.
    Darrabie MD; Arciniegas AJ; Mantilla JG; Mishra R; Vera MP; Santacruz L; Jacobs DO
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H539-48. PubMed ID: 22752631
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Screening for
    Chakouri N; Farah C; Matecki S; Amedro P; Vincenti M; Saumet L; Vergely L; Sirvent N; Lacampagne A; Cazorla O
    Theranostics; 2020; 10(18):8130-8142. PubMed ID: 32724462
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity.
    Gioffré S; Ricci V; Vavassori C; Ruggeri C; Chiesa M; Alfieri I; Zorzan S; Buzzetti M; Milano G; Scopece A; Castiglioni L; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y
    Biomed Pharmacother; 2019 Feb; 110():1-8. PubMed ID: 30453253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.